MAIA Maia Biotechnology, Inc.

Fundamentals / CIK 0001878313 / USD

Maia Biotechnology, Inc. reported $22.10M in total assets and a net loss of $25.12M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MAIA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$21.74MFY 2021 Net Income: -$12.50M2021FY 2022 Revenue: $0FY 2022 Net Income: -$16.22M2022FY 2023 Revenue: $0FY 2023 Net Income: -$19.77M2023FY 2024 Revenue: $0FY 2024 Net Income: -$23.25M2024FY 2025 Net Income: -$22.40M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $0 $0 $0 --
Research & Development $454K $10.01M $11.11M $8.93M $3.50M
Total Operating Expenses $24.27M $16.96M $20.18M $16.18M $7.79M
Operating Income -$24.27M -$16.96M -$20.18M -$16.18M -$7.79M
Interest Income -- $318K $34K $1.9K $2.0K
Interest Expense -- $57 $6.9K $7.0K $828K
Income Before Tax -$22.39M -$23.25M -$19.80M -$15.80M -$12.60M
Income Tax Expense $2.0K $2.0K -- -- --
Net Income -$22.40M -$23.25M -$19.77M -$16.22M -$12.50M
Basic EPS -$0.70 -$1.05 -$1.49 -$1.75 -$2.37
Diluted EPS -$0.70 -$1.05 -$1.49 -$1.75 -$2.37
Basic Shares Outstanding 32.1M 22.2M 13.3M 9.3M 5.3M
Diluted Shares Outstanding 32.1M 22.2M 13.3M 9.3M 5.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.34M $179K $44K $1.88M $6.36M -$3.17M $3.20M $2.97M
Total Operating Expenses $8.02M $8.32M $6.95M $4.32M $9.36M $5.17M $5.43M $5.00M
Operating Income -$8.02M -$8.32M -$6.95M -$4.32M -$9.36M -$5.17M -$5.43M -$5.00M
Interest Income -- -- -- -- -- $80K $82K $80K
Income Tax Expense -- -- $339 $2.0K $0 $0 $0 $2.0K
Net Income -$7.18M -$7.94M -$6.37M -$3.63M -$8.90M -$5.35M -$4.52M -$3.57M
Basic EPS -$0.12 -$0.13 -$0.14 -- -$0.27 -$0.18 -$0.16 --
Diluted EPS -$0.12 -$0.13 -$0.14 -- -$0.27 -$0.18 -$0.16 --
Basic Shares Outstanding 60.9M 60.8M 45.2M -- 33.2M 30.3M 27.7M --
Diluted Shares Outstanding 60.9M 60.8M 45.2M -- 33.2M 30.3M 27.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $0 $0 $0 $0 $0
Cash & Short-Term Investments $0 $0 $0 $0 $0
Total Current Assets $9.70M $10.15M $7.56M $11.81M $10.67M
Other Non-Current Assets $2.8K $2.8K $2.8K $2.8K $3.1K
Total Non-Current Assets $2.8K $2.8K $2.8K $214K $655K
Total Assets $9.70M $10.16M $7.57M $12.02M $11.33M
Accounts Payable $2.04M $1.51M $1.64M $1.17M $960K
Total Current Liabilities $5.84M $3.83M $4.94M $3.27M $2.15M
Total Non-Current Liabilities $1.49M $2.69M $2.15M $245K $0
Total Liabilities $7.33M $6.52M $7.09M $3.51M $2.15M
Common Stock $3.9K $2.6K $1.7K $1.1K $758
Retained Earnings -$109.6M -$87.23M -$63.98M -$44.21M -$28.44M
Accumulated Other Comp. Income -$50K -$31K -$16K -$16K --
Total Stockholders' Equity $2.38M $3.63M $478K -- --
Total Equity $2.38M $3.63M $478K $8.51M $9.18M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $0 $0 $0 $0 $0 $0 $0 $0
Cash & Short-Term Investments $0 $0 $0 $0 $0 $0 $0 $0
Total Current Assets $22.10M $28.24M $35.32M $9.70M $11.75M $11.04M $11.86M $10.15M
Other Non-Current Assets $2.8K $2.8K $7.5K $2.8K $27K $2.8K $2.8K $2.8K
Total Non-Current Assets $2.8K $2.8K $7.5K $2.8K $27K $2.8K $2.8K $2.8K
Total Assets $22.10M $28.24M $35.32M $9.70M $11.78M $11.05M $11.86M $10.16M
Accounts Payable $4.12M $2.84M $2.98M $2.04M $3.18M $1.72M $1.84M $1.51M
Total Current Liabilities $6.47M $6.26M $6.32M $5.84M $9.99M $5.04M $5.06M $3.83M
Total Non-Current Liabilities $957K $1.31M $1.24M $1.49M $1.75M $2.13M $1.86M $2.69M
Total Liabilities $7.43M $7.57M $7.56M $7.33M $11.74M $7.17M $6.92M $6.52M
Common Stock $6.2K $6.1K $6.1K $3.9K $3.4K $3.2K $3.0K $2.6K
Retained Earnings -$131.1M -$123.9M -$116.0M -$109.6M -$106.0M -$97.10M -$91.75M -$87.23M
Accumulated Other Comp. Income $11K -$42K -$40K -$50K -$31K -$30K -$38K -$31K
Total Stockholders' Equity $14.67M $20.68M $27.76M $2.38M $42K $3.88M $4.94M $3.63M
Total Equity $14.67M $20.68M $27.76M $2.38M $42K $3.88M $4.94M $3.63M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$22.40M -$23.25M -$19.77M -$15.77M -$12.58M
Stock-Based Compensation $2.63M $1.91M $3.09M $2.32M $2.72M
Change in Receivables -- -- $158K -$269K --
Change in Payables $520K -$119K $472K $211K $806K
Operating Cash Flow -$18.84M -$15.70M -$13.07M -$12.10M -$4.12M
Common Stock Issued $328K $659K -- $2.47M $5.74M
Financing Cash Flow $17.91M $18.18M $9.27M $12.48M $14.03M
Net Change in Cash -- $2.45M -$3.80M $377K $9.91M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.18M -$7.94M -$6.37M -$3.63M -$8.90M -$5.35M -$4.52M -$3.57M
Stock-Based Compensation $882K $724K $650K $811K $647K $802K $371K $693K
Change in Payables $1.28M -$145K $941K -$1.14M $1.45M -$153K $359K $369K
Operating Cash Flow -$6.31M -$6.75M -$5.31M -$7.02M -$3.49M -$4.14M -$4.20M -$3.91M
Common Stock Issued -- -- -- -$6.45M $117K $61K $1.52M --
Financing Cash Flow $0 -$65K $31.05M $4.80M $4.23M $3.41M $5.46M $4.85M
Net Change in Cash -- -- -- -- -- -- $1.26M $911K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -942.7% -639.8% -4140.8% -- --
Return on Assets (ROA) -230.8% -229.0% -261.3% -134.9% -110.4%
Current Ratio 1.66x 2.65x 1.53x 3.61x 4.97x
Quick Ratio 0.00x 0.00x 0.00x 0.00x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -171.2% -129.8% -87.3% -942.7% -53610.1% -417.2% -398.7% -639.8%
Return on Assets (ROA) -113.7% -95.1% -68.6% -230.8% -189.6% -146.4% -166.1% -229.0%
Current Ratio 3.41x 4.51x 5.59x 1.66x 1.18x 2.19x 2.35x 2.65x
Quick Ratio 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001878313) · from March 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal